Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)
ClinicalTrials.gov study NCT00206726. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age
ClinicalTrials.gov study NCT01011894. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01351896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Understanding Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04028531. IPD Sharing: YES. Countries: 1. Publications: 0.
Campath Maintenance in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00587847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00536341. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01808326. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00935792. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01369849. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cel
ClinicalTrials.gov study NCT06846671. IPD Sharing: YES. Countries: 12. Publications: 0.
Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency
ClinicalTrials.gov study NCT02553447. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT03207555. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01466153. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT04155840. IPD Sharing: NO. Countries: 1. Publications: 0.
Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01403246. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00612716. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab
ClinicalTrials.gov study NCT01123356. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04657094. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01465230. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01113632. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.